dc.contributor.author | Halise Inci, Gul | |
dc.contributor.author | Parham, Taslimi | |
dc.contributor.author | Ilhami, Gulcin | |
dc.contributor.author | Claudiu T., Supuran | |
dc.date.accessioned | 2019-05-17T07:27:13Z | |
dc.date.available | 2019-05-17T07:27:13Z | |
dc.date.issued | 2017 | |
dc.identifier.uri | http://hdl.handle.net/11772/1188 | |
dc.description.abstract | 4-(3-(4-Substituted-phenyl)-5-phenyl-4,5-dihydro-1H-pyrazol-1-yl) benzenesulfonamides (9-16) were successfully synthesized and their chemical structures were confirmed by H-1 NMR, C-13 NMR, and HRMS spectra. Carbonic anhydrase I and II inhibitory effects of the compounds were investigated. Ki values of the compounds were in the range of 316.7 +/- 9.6-533.1 +/- 187.8nM towards hCA I and 412.5 +/- 115.4-624.6 +/- 168.2nM towards hCA II isoenzymes. While K-i values of the reference compound Acetazolamide were 278.8 +/- 44.3 nM and 293.4 +/- 46.4 nM towards hCA I and hCA II izoenzymes, respectively. Compound 14 with bromine and compound 13 with fluorine substituents can be considered as the leader compounds of the series because of the lowest K-i values in series to make further detailed carbonic anhydrase inhibiton studies. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Informa | en_US |
dc.relation.isversionof | 10.1080/14756366.2016.1244533 | en_US |
dc.rights | info:eu-repo/semantics/restrictedAccess | en_US |
dc.subject | Carbonic anhydrase | en_US |
dc.subject | Enzyme | en_US |
dc.subject | Pyrazoline | en_US |
dc.subject | Sulfonamide | en_US |
dc.title | Synthesis, carbonic anhydrase I and II inhibition studies of the 1,3,5-trisubstituted-pyrazolines | en_US |
dc.type | article | en_US |
dc.relation.journal | Journal of Enzyme Inhibition and Medicinal Chemistry | en_US |
dc.contributor.department | Bartın Üniversitesi, Fen Fakültesi, Biyoteknoloji Bölümü | en_US |
dc.identifier.volume | 32 | en_US |
dc.identifier.issue | 1 | en_US |
dc.identifier.startpage | 189 | en_US |
dc.identifier.endpage | 192 | en_US |